{"AllianceGenome": "26727", "HGNC": "26727", "MIM": "615099", "_id": "151176", "_version": 1, "accession": {"genomic": ["AC016757.10", "CP068276.2", "NC_000002.12", "NC_060926.1"], "protein": ["AAH47423.1", "AAY24335.1", "AHL84165.1", "BAC04336.1", "NP_001278761.1", "Q4G0M1.2"], "rna": ["AI362696.1", "AK094353.1", "BC031951.1", "BC047423.1", "BC063413.1", "H05276.1", "KF984314.1", "NM_001291832.2", "NM_152521.1"], "translation": [{"protein": "BAC04336.1", "rna": "AK094353.1"}, {"protein": "NP_001278761.1", "rna": "NM_001291832.2"}, {"protein": "AAH47423.1", "rna": "BC047423.1"}, {"protein": "AHL84165.1", "rna": "KF984314.1"}]}, "alias": ["C1QTNF15", "CTRP15", "FAM132B"], "ensembl": {"gene": "ENSG00000178752", "protein": ["ENSP00000343261", "ENSP00000349855", "ENSP00000442304"], "transcript": ["ENST00000344233", "ENST00000357303", "ENST00000473274", "ENST00000479091", "ENST00000481917", "ENST00000486834", "ENST00000546354"], "translation": [{"protein": "ENSP00000442304", "rna": "ENST00000546354"}, {"protein": "ENSP00000343261", "rna": "ENST00000344233"}, {"protein": "ENSP00000349855", "rna": "ENST00000357303"}], "type_of_gene": "protein_coding"}, "entrezgene": "151176", "exons": [{"cdsend": 238167054, "cdsstart": 238159007, "chr": "2", "position": [[238158969, 238159205], [238161593, 238161716], [238162735, 238162838], [238163736, 238163999], [238164074, 238164183], [238164269, 238164360], [238165605, 238165684], [238166955, 238168890]], "strand": 1, "transcript": "NM_001291832", "txend": 238168890, "txstart": 238158969}], "exons_hg19": [{"cdsend": 239075695, "cdsstart": 239067648, "chr": "2", "position": [[239067610, 239067846], [239070234, 239070357], [239071376, 239071479], [239072377, 239072640], [239072715, 239072824], [239072910, 239073001], [239074246, 239074325], [239075596, 239077531]], "strand": 1, "transcript": "NM_001291832", "txend": 239077531, "txstart": 239067610}], "generif": [{"pubmed": 22351773, "text": "Myonectin links skeletal muscle to lipid homeostasis in liver and adipose tissue in response to alterations in energy state, revealing a novel myonectin-mediated metabolic circuit."}, {"pubmed": 26978524, "text": "In hemodialysis patients DA and CERA increased levels of ERFE that regulated hepcidin 25 and led to iron mobilization from body stores during erythropoiesis."}, {"pubmed": 27146013, "text": "Data suggest hepcidin is the master regulator of systemic iron homeostasis; hepcidin levels are suppressed when erythropoiesis is stimulated; the erythroid-derived hormone erythroferrone appears to be a convincing candidate for link between increased erythropoiesis and hepcidin suppression. [REVIEW]"}, {"pubmed": 27540014, "text": "FAM132b expression is upregulated in Congenital Dyserythropoietic Anemia type II."}, {"pubmed": 28666715, "text": "From a clinical point of view, erythroferrone could become a useful biological marker of iron metabolism and a therapeutic target. [review]"}, {"pubmed": 29419424, "text": "serum ERFE levels acutely increase in response to EPO in the setting of normal or impaired kidney function"}, {"pubmed": 30303269, "text": "Serum CTRP15 concentrations were associated with the key components of MetS and insulin resistance."}, {"pubmed": 31292266, "text": "The expression of the variant ERFE transcript that was restricted to SF3B1-mutated erythroblasts decreased in lenalidomide-responsive anemic patients, identifying variant ERFE as a specific biomarker of clonal erythropoiesis."}, {"pubmed": 31400017, "text": "A recurrent low-frequency variant, A260S, in the ERFE gene was found in 12.5% of congenital dyserythropoietic anemia type II patients with a severe phenotype. This variant leads to increased levels of ERFE, with subsequently marked impairment of iron regulation pathways at the hepatic level. It modified iron overload by impairing the BMP/SMAD pathway."}, {"pubmed": 31608708, "text": "Higher serum level of CTRP15 in patients with coronary artery disease is associated with disease severity, body mass index and insulin resistance."}, {"pubmed": 31834456, "text": "using the ERFE gene expression, combined with serum hepcidin estimation, can substantiate the role of estimated TS% as a promising tool in screening for iron overload in beta-TM patients."}, {"pubmed": 31965030, "text": "Implications of C1q/TNF-related protein superfamily in patients with coronary artery disease."}, {"pubmed": 32314610, "text": "Association of decreased myonectin levels with metabolic and hormonal disturbance in polycystic ovary syndrome."}, {"pubmed": 32324886, "text": "Interplay of erythropoietin, fibroblast growth factor 23, and erythroferrone in patients with hereditary hemolytic anemia."}, {"pubmed": 32866306, "text": "Disordered serum erythroferrone and hepcidin levels as indicators of the spontaneous abortion occurrence during early pregnancy in humans."}, {"pubmed": 33372284, "text": "Erythroferrone structure, function, and physiology: Iron homeostasis and beyond."}, {"pubmed": 33486765, "text": "High erythroferrone expression in CD71(+) erythroid progenitors predicts superior survival in myelodysplastic syndromes."}, {"pubmed": 33676229, "text": "The impacts of C1q/TNF-related protein-15 and adiponectin on Interleukin-6 and tumor necrosis factor-alpha in primary macrophages of patients with coronary artery diseases."}, {"pubmed": 34236433, "text": "Umbilical Cord Erythroferrone Is Inversely Associated with Hepcidin, but Does Not Capture the Most Variability in Iron Status of Neonates Born to Teens Carrying Singletons and Women Carrying Multiples."}, {"pubmed": 34283879, "text": "Differentiating iron-loading anemias using a newly developed and analytically validated ELISA for human serum erythroferrone."}, {"pubmed": 34310730, "text": "Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplant."}, {"pubmed": 34376791, "text": "Serum erythroferrone levels during the first month of life in premature infants."}, {"pubmed": 35700181, "text": "Plasma Complement C1q/tumor necrosis factor-related protein 15 concentration is associated with polycystic ovary syndrome."}, {"pubmed": 36675239, "text": "In Silico Pan-Cancer Analysis Reveals Prognostic Role of the Erythroferrone (ERFE) Gene in Human Malignancies."}, {"pubmed": 37253412, "text": "Placental Erythroferrone and Erythropoietin mRNA Expression is not Associated with Maternal or Neonatal Iron Status in Adolescents Carrying Singletons and Adult Women Carrying Multiples."}, {"pubmed": 37866631, "text": "Characterization of erythroferrone structural domains relevant to its iron-regulatory function."}, {"pubmed": 37949218, "text": "Characterization of erythroferrone oligomerization and its impact on BMP antagonism."}], "genomic_pos": {"chr": "2", "end": 238168900, "ensemblgene": "ENSG00000178752", "start": 238158970, "strand": 1}, "genomic_pos_hg19": {"chr": "2", "end": 239077541, "start": 239067623, "strand": 1}, "go": {"BP": [{"evidence": "ISS", "gocategory": "BP", "id": "GO:0006879", "qualifier": "involved_in", "term": "intracellular iron ion homeostasis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0007165", "qualifier": "involved_in", "term": "signal transduction"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0010507", "qualifier": "involved_in", "term": "negative regulation of autophagy"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0015908", "qualifier": "involved_in", "term": "fatty acid transport"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0019217", "qualifier": "involved_in", "term": "regulation of fatty acid metabolic process"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0043066", "qualifier": "involved_in", "term": "negative regulation of apoptotic process"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0045668", "qualifier": "involved_in", "term": "negative regulation of osteoblast differentiation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0045671", "qualifier": "acts_upstream_of", "term": "negative regulation of osteoclast differentiation"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0045721", "qualifier": "involved_in", "term": "negative regulation of gluconeogenesis"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0046326", "qualifier": "involved_in", "term": "positive regulation of glucose import"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0046628", "qualifier": "involved_in", "term": "positive regulation of insulin receptor signaling pathway"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0051649", "qualifier": "involved_in", "term": "establishment of localization in cell"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0051897", "qualifier": "involved_in", "term": "positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:2000193", "qualifier": "involved_in", "term": "positive regulation of fatty acid transport"}], "CC": [{"evidence": "ISS", "gocategory": "CC", "id": "GO:0005576", "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005615", "qualifier": "is_active_in", "term": "extracellular space"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0005615", "qualifier": "located_in", "term": "extracellular space"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0005179", "qualifier": "enables", "term": "hormone activity"}, {"category": "MF", "evidence": "ISS", "id": "GO:0005179", "qualifier": "enables", "term": "hormone activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0042802", "qualifier": "enables", "term": "identical protein binding"}]}, "homologene": {"genes": [[9544, 706226], [9598, 101058062], [9606, 151176], [9913, 101905782], [10090, 227358], [10116, 681056]], "id": 87245}, "interpro": [{"desc": "C1q domain", "id": "IPR001073", "short_desc": "C1q_dom"}, {"desc": "Tumour necrosis factor-like domain superfamily", "id": "IPR008983", "short_desc": "Tumour_necrosis_fac-like_dom"}], "map_location": "2q37.3", "name": "erythroferrone", "other_names": ["complement C1q tumor necrosis factor-related protein 15", "erythroferrone", "family with sequence similarity 132, member B", "myonectin", "protein FAM132B"], "pantherdb": {"HGNC": "26727", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "3606476", "ortholog_type": "LDO", "panther_family": "PTHR24019", "taxid": 10090, "uniprot_kb": "Q6PGN1"}, {"RGD": "1584688", "ortholog_type": "LDO", "panther_family": "PTHR24019", "taxid": 10116, "uniprot_kb": "D4AB34"}, {"ZFIN": "ZDB-GENE-061215-120", "ortholog_type": "O", "panther_family": "PTHR24019", "taxid": 7955, "uniprot_kb": "A1A5X5"}], "uniprot_kb": "Q4G0M1"}, "pharmgkb": "PA162386102", "pharos": {"target_id": 13276, "tdl": "Tbio"}, "prosite": "PS50871", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": {"id": "GNF225591", "relationship": "is"}, "NIBRI_hs-Secretome_pDEST": {"id": "GNF335235", "relationship": "is"}}, "refseq": {"genomic": ["NC_000002.12", "NC_060926.1"], "protein": "NP_001278761.1", "rna": ["NM_001291832.2", "NM_152521.1"], "translation": {"protein": "NP_001278761.1", "rna": "NM_001291832.2"}}, "reporter": {"HG-U133_Plus_2": "229622_at", "HG-U95B": "52665_at", "HTA-2_0": "TC02001451.hg.1", "HuEx-1_0": "2534717", "HuGene-1_1": "8049620", "HuGene-2_1": "16893068"}, "summary": "Predicted to enable hormone activity. Predicted to be involved in several processes, including negative regulation of gluconeogenesis; positive regulation of glucose import; and positive regulation of insulin receptor signaling pathway. Predicted to act upstream of or within positive regulation of fatty acid transport and regulation of fatty acid metabolic process. Predicted to be located in extracellular region. Predicted to be active in extracellular space. [provided by Alliance of Genome Resources, Apr 2022]", "symbol": "ERFE", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C2239422"}, "unigene": ["Hs.742300", "Hs.24951"], "uniprot": {"Swiss-Prot": "Q4G0M1", "TrEMBL": ["H0Y2X4", "H7BY19"]}}